Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone. [electronic resource]
Publication details: World journal of oncology Feb 2020Description: 33-36 p. digitalISSN:- 1920-454X
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.